Articles From: UPDATE: U.S. stocks end higher; Herbalife gain best ever to SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in OvaScience, Inc. of Class Action Lawsuit and Upcoming Deadline -- OVAS


By Anora Mahmudova and Sara Sjolin, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market closed modestly higher, boosted by better-than-expected inflation and housing reports as well as a flood of second-quarter earnings reports.
Sign-up for UPDATE: U.S. stocks end higher; Herbalife gain best ever investment picks
By Anora Mahmudova and Sara Sjolin, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market closed modestly higher, boosted by better-than-expected inflation and housing reports as well as a flood of second-quarter earnings reports.
Sign-up for UPDATE: U.S. stocks close up; Herbalife gain best ever investment picks
By Anora Mahmudova and Sara Sjolin, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market moved higher, boosted by better-than-expected inflation and housing reports as well as a flood of second-quarter earnings reports.
Sign-up for UPDATE: U.S. stocks rise; Chipotle rallies on results investment picks
By Anora Mahmudova and Sara Sjolin, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market opened higher, as investors digested second-quarter results coming in through thick and fast.
Sign-up for UPDATE: U.S. stocks open higher; CPI in line with forecasts investment picks
2014/9/10
By Anora Mahmudova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks rose Wednesday, bouncing back from morning losses, as Apple Inc. and other tech stocks helped lead the way higher.
Sign-up for MARKET SNAPSHOT: U.S. Stocks End Higher, Helped By Apple's 3% Jump investment picks
2014/9/10
By Anora Mahmudova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks rose Wednesday, bouncing back from morning losses, as Apple Inc. and other tech stocks helped lead the way higher.
Sign-up for UPDATE: U.S. stocks end higher, helped by Apple's 3% jump investment picks
2014/7/8
By Anora Mahmudova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- So-called momentum plays led a selloff in U.S. stocks on Tuesday that pulled the Dow Jones Industrial Average and S&P 500 further from record levels.
Sign-up for UPDATE: U.S. stocks fall; momentum plays hit hard investment picks
2014/7/8
By Anora Mahmudova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks sold off on Tuesday with so-called high-growth momentum plays hit hardest, while the Dow Jones Industrial Average and S&P 500 retreated further from recent peaks.
Sign-up for UPDATE: U.S. stock-market losses led by momentum plays investment picks
2014/7/17
By Anora Mahmudova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks ended sharply lower Thursday as selling took hold after a Malaysia Airlines jet crashed near the Ukraine-Russia border.
Sign-up for UPDATE: U.S. stocks sell off after Malaysia Airlines crash in Ukraine investment picks
2014/7/17
By Anora Mahmudova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks dropped Thursday as investors focused on fresh Russia-Ukraine tensions and reports of a Malaysia Airlines jet crashing in Ukraine.
Sign-up for UPDATE: Malaysia Airlines crash in Ukraine rocks stocks investment picks
2014/7/17
By Anora Mahmudova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch)--U.S. stocks lost ground Thursday as investors focused on fresh Russia-Ukraine tensions, and reports of a Malaysia Airlines jet crashing in Ukraine.
Sign-up for UPDATE: U.S. stocks slip as Ukraine worries weigh investment picks
2014/7/30
By Anora Mahmudova and Victor Reklaitis, MarketWatch Twitter jumps -Anora Mahmudova; 415-439-6400; AskNewswires@dowjones.com NEW YORK (MarketWatch) -- U.S. stocks finished a choppy session slightly higher, as the Federal Reserve appeared to soothe fears that it might start raising interest rates sooner than anticipated.
Sign-up for UPDATE: S&P 500 ekes out gains as Fed calms rate-hike fears investment picks
By Anora Mahmudova and Victor Reklaitis, MarketWatch Twitter jumps -Anora Mahmudova; 415-439-6400; AskNewswires@dowjones.com NEW YORK (MarketWatch)--U.S. stocks pared losses on Wednesday afternoon, with the S&P 500 turning positive, as the Federal Reserve appeared to soothe fears that it might start raising interest rates sooner than anticipated.
Sign-up for UPDATE: S&P 500 turns positive as Fed calms rate-hike fears investment picks
BEIJING, July 2, 2014 (GLOBE NEWSWIRE) -- ChinaNet Online Holdings, Inc. (Nasdaq:CNET) (the "ChinaNet" or "Company"), a leading B2B (business to business) Internet technology company focusing on providing online-to-offline ("O2O") sales channel expansion services for small and medium-sized enterprises ("SMEs") and entrepreneurial management and networking services for entrepreneurs in the People's Republic of China, today announced that on June 30, 2014, NASDAQ granted an exception to enable the Company to regain compliance with NASDAQ's filing requirements set forth in Listing Rules 5250(c)(1) (the "Rule"). The Company must file the Form 10-Q for the period ended March 31, 2014 (the "Form 10-Q') as required by the Rule on or before July 31, 2014.
Sign-up for ChinaNet Online Holdings Receives Extension to Regain Compliance With NASDAQ Listing Rules investment picks
2014/7/9
By Anthony Harrup and Juan Montes MEXICO CITY --
Sign-up for América Móvil to sell assets, cut Mexican market share investment picks
2014/7/11
By Anthony Mirhaydari As they say, every new beginning is some other new beginning's end.
Sign-up for How to prepare for the end of cheap money investment picks
Qumu Corporation (NASDAQ: QUMU), a leader in enterprise video platforms, today announced the closing of its previously announced all-cash sale of the Rimage disc publishing assets to Redwood Acquisition, Inc., a wholly-owned subsidiary of Equus Holdings, Inc. Redwood Acquisition is now known as Rimage Corporation.
Sign-up for Qumu Corporation Closes Sale of Disc Publishing Assets investment picks
2014/9/26
By Anton Troianovski in Berlin and Gregory L.
Sign-up for Ukraine's Gas Deal With Russia Reflects Shifting Pressures investment picks
2014/9/18
By Anupreeta Das and Craig Karmin Invitations to a dinner party from Bill and Melinda Gates at their mansion near Seattle in February included an unusual request: Wear pink or platinum.
Sign-up for This Man's Job: Make Bill Gates Richer investment picks
Accenture (NYSE:ACN) was named the leader of policy administration deals for its Accenture Life Insurance Platform (ALIP) solution in Celent’s annual report: “North American Insurance Software Deal Trends, 2014 Life/Annuity/Health Edition.” The report analyzes deal data provided by software vendors active in insurance in North America.
Sign-up for Accenture Named Leader of Policy Administration Deals in New Celent Research Report on Life Insurance and Annuity Software Deals in North America investment picks
- Abbott Achieved Top Industry Scores for Economic and Social Performance - Company Recognized for Sustainability Leadership for 10 Consecutive Years ABBOTT PARK, Ill., Sept.
Sign-up for Abbott Once Again Named the Industry Leader for Responsible and Sustainable Business on the Dow Jones Sustainability Index (DJSI) investment picks
OvaScience℠ (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Rodman & Renshaw 16 th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., on Wednesday, September 10, 2014 at 10:25 am ET at the New York Palace Hotel.
Sign-up for OvaScience to Present at the Rodman & Renshaw/H.C. Wainwright Annual Global Investment Conference investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today reported second quarter 2014 financial results and highlighted recent accomplishments.
Sign-up for OvaScience Reports Second Quarter 2014 Financial Results investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Wedbush Securities Life Sciences Management Access Conference on Wednesday, August 13, 2014 at 8:35 am ET at Le Parker Meridian in New York.
Sign-up for OvaScience to Present at the Wedbush Life Sciences Management Access Conference investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today Michelle Dipp, M.D, Ph.D., Chief Executive Officer at OvaScience, has received the Ten Outstanding Young Leaders (TOYL) Award from the Greater Boston Chamber of Commerce.
Sign-up for OvaScience CEO Michelle Dipp Named Outstanding Young Leader investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today the appointment of Jeffrey Young to Chief Financial Officer.
Sign-up for OvaScience Appoints Jeffrey Young to Chief Financial Officer investment picks
NEW YORK, June 20, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against OvaScience, Inc. ("OvaScience" or the "Company") (Nasdaq:OVAS) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in OvaScience, Inc. of Class Action Lawsuit and Upcoming Deadline -- OVAS investment picks
NEW YORK , July 3, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against OvaScience, Inc. ("OvaScience" or the "Company") (NASDAQ: OVAS) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against OvaScience, Inc. and Certain Officers - OVAS investment picks
NEW YORK, July 20, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against OvaScience, Inc ("OvaScience" or the "Company") (Nasdaq:OVAS) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in OvaScience, Inc. of Class Action Lawsuit and Upcoming Deadline -- OVAS investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: UPDATE: U.S. stocks end higher; Herbalife gain best ever to SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in OvaScience, Inc. of Class Action Lawsuit and Upcoming Deadline -- OVAS
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices